![Pierre F. Dodion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre F. Dodion
Corporate Officer/Principal at
American Society of Clinical Oncology, Inc.
Profile
Pierre F.
Dodion currently works at American Society of Clinical Oncology, Inc., as Member.
Dr. Dodion also formerly worked at Pfizer Inc., as Executive Director-Oncology from 2006 to 2007, Aventis SA, as Senior Medical Director from 1997 to 2002, Novartis AG, as Executive Director-Global Strategy & Marketing from 2002 to 2006, ARIAD Pharmaceuticals, Inc., as Senior Vice President-Corporate Development from 2011 to 2012, Innate Pharma SA, as Chief Medical Officer & Executive VP from 2014 to 2020, and Nordic Nanovector ASA, as Chief Medical Officer.
Dr. Dodion received his Masters Business Admin degree from St. Joseph's University and doctorate degree from Université Libre de Bruxelles.
Pierre F. Dodion active positions
| Companies | Position | Start |
|---|---|---|
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Former positions of Pierre F. Dodion
| Companies | Position | End |
|---|---|---|
| INNATE PHARMA | Chief Tech/Sci/R&D Officer | 2020-07-15 |
| PFIZER INC. | Corporate Officer/Principal | 2006-12-31 |
| NOVARTIS AG | Sales & Marketing | 2005-12-31 |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Chief Tech/Sci/R&D Officer | 2001-12-31 |
| THOR MEDICAL | Chief Tech/Sci/R&D Officer | - |
Training of Pierre F. Dodion
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Pierre F. Dodion
